Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication ...

Researchers from two labs in the Human Biology division at Fred Hutch Cancer Center recently published two studies aimed at better understanding how a notorious gene fusion — ZFTA-RELA — drives rare ...

Scientists at Oregon Health & Science University have developed a new molecule that could open the door to treating triple-negative breast cancer, one of the most aggressive and difficult-to-treat ...

Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication romiplostim can effectively ...

Pharmacokinetic analysis revealed sustained activity at 15 days, a finding corroborated by imaging that demonstrated prolonged tumor retention of the therapeutic agent. Importantly, researchers found ...

LOS ANGELES, CA – The University of California, Los Angeles, has received a bequest of more than $4 million that will permanently strengthen the training of future physician scientists, marking one of ...

The Amarillo Symphony has announced Tom and Doris Nichols as the recipients of the 2026 Beethoven Society Award and will ...

Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.

As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) reduced the risk of disease progression or death versus ...

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a managing advanced disease in renal and rare cancer session and a Society of Urologic Oncology (SUO) lecture ...

| DelveInsight The surgical robotic systems market is witnessing significant growth, driven by the rising adoption of minimally invasive procedures and the increasing demand for precision and improved ...